Valuation: Haemonetics Corporation

Market Cap 3.94B 3.43B 3.2B 2.94B 5.54B 376B 5.64B 37.74B 14.78B 187B 14.82B 14.49B 618B P/E 2027 *
22.1x
P/E 2028 * 19.5x
Enterprise Value 4.62B 4.01B 3.75B 3.44B 6.48B 440B 6.6B 44.17B 17.3B 219B 17.34B 16.96B 724B EV / Sales 2027 *
3.29x
EV / Sales 2028 * 2.94x
Free-Float
98.74%
Yield 2027 *
2.3%
Yield 2028 * -
1 day+1.46%
1 week+8.61%
Current month+1.46%
1 month+15.61%
3 months+46.46%
6 months+33.81%
Current year+8.28%
1 week 81.72
Extreme 81.7199
88.58
1 month 71.81
Extreme 71.81
88.58
Current year 51
Extreme 51
88.58
1 year 47.32
Extreme 47.315
88.58
3 years 47.32
Extreme 47.315
97.97
5 years 43.5
Extreme 43.5
97.97
10 years 32.76
Extreme 32.76
142.11
Manager TitleAgeSince
Chief Executive Officer 62 16/05/2016
Director of Finance/CFO 55 11/04/2022
Chief Operating Officer 56 01/04/2025
Director TitleAgeSince
Director/Board Member 73 01/01/2006
Director/Board Member 62 16/05/2016
Director/Board Member 71 18/10/2017
Date Insider Type Main position Quantity % Market Cap.
24/7/26 Free

Director

2,538 0.0056%
24/7/26 Free

Director

2,538 0.0056%
24/7/26 Free

Director

2,538 0.0056%
Change 5-day change 1-year change 3-year change Capi.($)
+1.46%+8.61%+16.08%-5.29% 3.94B
+1.34%+2.52%-15.85%-0.39% 185B
+1.51%+2.92%-2.98%+2.59% 111B
-0.95%-0.89%+6.94%+61.15% 60B
+2.63%+9.46%+43.51%+59.34% 53.9B
+2.77%+7.10%-3.49%-36.65% 46.9B
+3.03%+1.94% - - 34.22B
+4.63%+19.00%+10.13%-28.48% 32.95B
+2.05%+5.04%+45.42%-5.89% 24.49B
+1.86%+6.52%+2.54%+3.17% 22.67B
Average +2.03%+5.51%+11.37%+5.50% 57.54B
Weighted average by Cap. +1.71%+3.80%+1.66%+8.00%

Financials

2027 *2028 *
Net sales 1.4B 1.22B 1.14B 1.04B 1.97B 134B 2B 13.41B 5.25B 66.63B 5.27B 5.15B 220B 1.47B 1.28B 1.2B 1.1B 2.07B 141B 2.11B 14.1B 5.52B 70.07B 5.54B 5.41B 231B
Net income 176M 153M 143M 131M 248M 16.81B 252M 1.69B 661M 8.38B 663M 648M 27.65B 204M 177M 165M 152M 286M 19.43B 291M 1.95B 764M 9.69B 766M 749M 31.95B
Net Debt 672M 584M 546M 501M 944M 64.1B 961M 6.43B 2.52B 31.96B 2.53B 2.47B 105B 385M 334M 312M 287M 540M 36.68B 550M 3.68B 1.44B 18.29B 1.45B 1.41B 60.33B
Logo Haemonetics Corporation
Haemonetics Corporation is a medical technology company. Its solutions address critical medical needs, which includes a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers, and products to enable blood centers to collect in-demand blood components. Its Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. Its Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies (Hemostasis Management, Cell Salvage and Transfusion Management products). It also offers solutions for structural heart and endovascular procedures.
Employees
3,009
Date Price Change Volume
03/08/26 US$86.79 +1.46% 1,058,089
31/07/26 US$85.54 +0.85% 789,607
30/07/26 US$84.82 -0.70% 555,195
29/07/26 US$85.42 +3.49% 893,444
28/07/26 US$82.54 +3.29% 803,456
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
86.79USD
Average target price
87.90USD
Spread / Average Target
+1.28%

Quarterly revenue - Rate of surprise